Robinson Chandler 4
4 · Monopar Therapeutics · Filed Dec 8, 2025
Insider Transaction Report
Form 4
Robinson Chandler
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2025-12-02+16,753→ 16,753 totalExercise: $75.94Exp: 2035-12-02→ Common Stock (16,753 underlying) - Award
Restricted Stock Units
2025-12-02+49,133→ 121,732 totalExercise: $0.00→ Common Stock (49,133 underlying)
Footnotes (2)
- [F1]Options vest 6/48ths on June 30, 2026, and 1/48th per month thereafter.
- [F2]RSUs vest 6/48ths on June 30, 2026, and 3/48ths per quarter thereafter.